- Home
- »
- Animal Health
- »
-
South Africa Animal Health Market, Industry Report, 2033GVR Report cover
South Africa Animal Health Market (2025 - 2033) Size, Share & Trends Analysis Report By Product, By Disease, By Animal (Production Animals, Companion Animal), By Distribution Channel, By End Use, And Segment Forecasts
- Report ID: GVR-4-68040-717-7
- Number of Report Pages: 150
- Format: PDF
- Historical Range: 2021 - 2023
- Forecast Period: 2025 - 2033
- Industry: Healthcare
- Report Summary
- Table of Contents
- Segmentation
- Methodology
- Download FREE Sample
-
Download Sample Report
South Africa Animal Health Market Summary
The South Africa animal health market size was estimated at USD 958.47 million in 2024 and is projected to reach USD 1,808.59 million by 2033, growing at a CAGR of 7.4% from 2025 to 2033. The market is continuously growing driven by rising awareness of zoonotic and emerging diseases, increasing aquaculture and poultry production and government regulations and disease control programs.
Key Market Trends & Insights
- South Africa animal health market is expected to generate USD 1,024.95 million in revenue by 2025.
- By animal, the production animal segment held the largest market share of 64.00% in 2024.
- Based on product, the pharmaceuticals segment held the largest market share of 44.15% in 2024.
- By distribution channel, hospital/ clinic pharmacy segment held the largest market share in 2024.
Market Size & Forecast
- 2024 Market Size: USD 958.47 Million
- 2033 Projected Market Size: USD 1,808.59 Million
- CAGR (2025-2033): 7.4%
Global health concerns, such as COVID-19, highlighted the importance of controlling zoonotic diseases. South Africa, with its diverse wildlife and livestock populations, faces unique risks of disease spillovers. Zoonotic diseases, account for over 60% of all recognized human illnesses and nearly 75% of emerging infectious diseases (EIDs). In developing countries such as South Africa, EIDs carry a mortality rate of 47.3%, posing a serious public health challenge. Majority of these emerging infections (71.8%) originate from wildlife, underscoring the critical need for strengthened surveillance, early detection, and One Health approaches that integrate animal, human, and environmental health strategies.
South Africa is witnessing growth in the aquaculture and poultry industries, driven by rising demand for affordable animal protein. According to U.S. Department of Agriculture (USDA) report of September 2024, South Africa’s chicken meat production is expected to rise 3% to 1.65 million tons in 2025, driven by industry recovery post-HPAI. Consumption is set to grow 2% to 1.88 million tons, supported by easing food inflation. Poultry and aquaculture face high disease risks, including bacterial, viral, and parasitic infections that can devastate production. Farmers invest in vaccines, feed supplements, water treatments, and biosecurity solutions to maintain yields and profitability. Poultry, being the largest protein source, demands continuous innovation in health management, while aquaculture expansion brings new opportunities for specialized veterinary pharmaceuticals. This diversification of animal farming strengthens the market for veterinary medicines, diagnostics, and nutritional products, positioning aquaculture and poultry health as important growth drivers.
South Africa’s per Capita Consumption of Meat in kilogram per year
Product
Per Capita Consumption 2022/23
Per Capita Consumption 2023/24
Beef
16.4
16.5
Pork
5.8
5.7
Sheep, lamb, and goats
2.7
2.7
Poultry
35.95
34.79
Total Meat
60.81
59.69
Source: South Africa’s Department of Agriculture Land Reform and Rural Development data.
Government-led programs targeting zoonotic diseases, foot-and-mouth disease (FMD), and avian influenza are major growth drivers. Regulatory authorities like the Department of Agriculture, Land Reform, and Rural Development (DALRRD) work with veterinary organizations to strengthen surveillance, vaccination campaigns, and biosecurity frameworks. Policies supporting antimicrobial stewardship and responsible veterinary drug usage are improving product adoption while promoting safer animal-derived food supply chains. Moreover, ongoing trade negotiations push farmers to meet international animal health standards, creating demand for certified vaccines and medicines. This regulatory environment strengthens trust in veterinary products, accelerates adoption, and fosters growth in the South African market.
Market Concentration & Characteristics
The South Africa animal health market is significantly growing and experiencing accelerating growth, with multinational leaders like Zoetis, Elanco, Boehringer Ingelheim, and Merck dominating through advanced portfolios and strong distribution. However, regional players such as Ascendis Animal Health and Afrivet are gaining ground by offering affordable, locally adapted solutions, fostering competitive balance in the market.
Innovation in South Africa’s animal health market is moderate, driven by multinational companies introducing advanced vaccines, parasiticides, and biologics. Local players focus on cost-effective, practical solutions tailored to regional challenges such as zoonotic diseases and livestock productivity. In February 2023, Streamline, with floLIVE and CommsCloud, launched IoT livestock tracking in South Africa using NB-IoT and satellite connectivity, ensuring compliance, real-time visibility and cost reduction amid strict livestock movement regulations.

Mergers and acquisitions play a key role in shaping South Africa’s animal health market, with multinational giants expanding through local partnerships and acquisitions. Regional firms leverage strategic alliances to strengthen distribution and product portfolios. According to the March 2023 report, Boehringer Ingelheim’s LastMile initiative, with GALVmed and BMGF, enhances animal healthcare access for smallholder farmers in Africa, achieving 56 product registrations, training 40,000 farmers, and improving disease prevention, productivity, and livelihoods across eight countries.
Regulations in South Africa significantly impact the animal health market, balancing product safety with accessibility. The South African Health Products Regulatory Authority (SAHPRA) and Department of Agriculture oversee approvals, imports, and compliance. Strict regulatory frameworks ensure product quality but often delay market entry. In July 2025, South Africa’s draft regulations on live animal sea exports sparked debate, as welfare groups highlighted cruelty, urging public participation to oppose inhumane conditions and pushed for prioritizing animal welfare in government policy.
The market faces moderate pressure from product substitutes. Traditional remedies, compounded medicines, and off-label drug use sometimes replace commercial animal health products due to affordability and access issues. However, concerns about safety, efficacy, and regulatory restrictions limit substitutes. Increasing awareness of zoonotic risks and rising demand for veterinary-grade treatments are shifting preference toward regulated pharmaceuticals and biologics over informal alternatives.
End-user concentration in market is high, with commercial livestock producers, poultry integrators, and large veterinary groups driving demand. Companion animal owners represent a growing segment, particularly in urban centers. However, smaller-scale farmers and rural veterinary practices still rely on cost-sensitive solutions. The market is increasingly shaped by organized, large-scale users with stronger purchasing power and demand for advanced products.
Product Insights
Pharmaceuticals represent the largest segment in the South Africa animal health market with a revenue share of 44.15% in 2024, driven by rising demand for vaccines, antibiotics, antiparasitics, and sedatives to manage livestock and companion animal health. With zoonotic threats, livestock productivity challenges, and pet ownership on the rise, the pharmaceutical segment dominates due to its essential role in disease prevention, treatment, and herd management. Leading players such as Zoetis, Elanco, Boehringer Ingelheim, and emerging regional firms are expanding portfolios and distribution networks, while innovation in biologics and cost-effective formulations further strengthens this segment’s market share.
Others segment, comprising veterinary telehealth, veterinary software, and livestock monitoring solutions, is emerging as the fastest-growing area in South Africa’s animal health market. Increasing digital adoption, regulatory compliance needs, and the drive for efficiency in livestock management are fueling demand. Telehealth platforms enhance pet care accessibility, while advanced software streamlines veterinary operations. Livestock monitoring using IoT and satellite-enabled solutions improves disease detection, movement tracking, and biosecurity compliance. Together, these innovations address critical gaps in productivity, animal welfare, and regulatory adherence, positioning this segment as a key growth frontier.
Disease Insights
Cattle diseases represented the largest segment with a revenue share of 26.91% in 2024, driven by the country’s reliance on cattle for meat, milk, and livelihoods. The prevalence and threat of diseases such as Bovine Respiratory Disease (BRD), Mastitis, Bovine Viral Diarrhoea (BVD) Foot Mouth Disease (FMD), bovine tuberculosis, and tick-borne illnesses has created a sustained demand for vaccines, diagnostics, and therapeutics. Government vaccination programs, coupled with private sector initiatives, play a key role in disease control. With growing exports and domestic consumption, ensuring cattle health is vital for food security, trade, and farmer income, solidifying this segment’s dominant market position.
Fish and aquaculture diseases are emerging as the fastest-growing segment in the market, fueled by the rapid expansion of aquaculture to meet rising seafood demand. Challenges such as bacterial infections, parasitic infestations, and viral outbreaks threaten productivity and profitability, creating strong demand for vaccines, therapeutics, and water-quality management solutions. Government support for aquaculture development, coupled with private investments and technological innovations, are driving the adoption of advanced health management practices. For instance, in July 2023, A.L.P.H.A. Plus initiative, led by Zoetis and PHARMAQ, expanded sustainable livestock care across Sub-Saharan Africa, including tilapia, advancing aquaculture health through vaccines, diagnostics, and management, while scaling veterinary services and productivity. As aquaculture gains strategic importance for food security and exports, disease control is becoming a top priority, boosting this segment’s growth trajectory.
Animal Insights
Production animals stand as both the largest and fastest-growing segment of South Africa’s animal health market, driven by the country’s strong dependence on livestock for food security, economic growth, and exports. Cattle, poultry, sheep, and goats are central to the agricultural economy, supporting millions of smallholders and commercial farmers. Rising domestic demand for protein-rich foods such as meat, milk, and eggs, coupled with expanding export opportunities, continues to fuel this segment’s growth.
However, recurring disease challenges like foot-and-mouth disease, African swine fever, and avian influenza highlight the critical need for advanced veterinary pharmaceuticals, vaccines, diagnostics, and biosecurity measures. The government’s focus on improving animal health infrastructure, combined with private sector innovation in diagnostics and treatment, is further strengthening the market. Growing investments in sustainable livestock production, disease management technologies, and veterinary care ensure production animals remain the most dynamic and essential segment, driving resilience and long-term expansion in South Africa’s animal health sector. The government has strengthened vaccination drives and tightened biosecurity measures. A significant development is anticipated with the scheduled establishment of a local foot-and-mouth disease (FMD) vaccine manufacturing facility by 2026, marking a pivotal shift in control efforts.
Distribution Channel Insights
Hospital and clinic pharmacies represent the largest segment in South Africa’s animal health market, serving as the primary distribution channel for veterinary medicines, vaccines, and sedatives. Their role is crucial in ensuring timely access to essential treatments for both companion and production animals, particularly in managing infectious diseases and preventive care. With a robust network of veterinary hospitals and clinics, they enable regulated, high-quality dispensing practices, strengthening trust among farmers and pet owners. Growing livestock disease burden and pet healthcare demand further consolidate their dominance in the market.
E-commerce is the fastest-growing segment in South Africa’s animal health market, driven by increasing internet penetration, digital payments, and demand for convenient access to veterinary medicines, supplements, and pet products. Online platforms provide cost savings, home delivery, and subscription services, making them attractive for farmers, veterinarians, and pet owners. For example, Amazon South Africa expanded its marketplace in May 2024, adding pet food, and supplements. Featuring global and local brands, the move addresses shopper demand for everyday essentials with fast, reliable delivery. They also bridge distribution gaps in rural and underserved areas while offering added value through educational content and telehealth consultations. With growing consumer trust in digital platforms, e-commerce is reshaping the way animal healthcare solutions are accessed and delivered in South Africa.
End Use Insights
Veterinary hospitals and clinics represent the largest segment of South Africa’s animal health market, driven by rising pet ownership, demand for specialized care, and increasing awareness of preventive healthcare. These facilities provide comprehensive services including diagnostics, surgeries, vaccinations, and treatment for both companion and production animals. With urbanization and growing disposable incomes, more pet owners seek advanced medical support, while livestock farmers depend on clinics for herd health management. The segment’s growth is further supported by investments in modern infrastructure, skilled veterinary professionals, and adoption of innovative medical technologies.

Point-of-care (POC) and in-house testing is the fastest-growing segment in South Africa’s animal health market, driven by the need for rapid, accurate diagnostics in both companion and production animals. Veterinary clinics and farms are increasingly adopting portable diagnostic devices to detect conditions like FMD, mastitis, and parasitic infections quickly, enabling timely treatment and reducing economic losses. Advancements in diagnostic technologies, cost efficiency, and the push for better disease surveillance fuel the segment’s growth. This trend supports improved animal welfare, productivity, and farmer confidence in veterinary care.
South Africa Animal Health Market Trends
The South Africa animal health market is competitive, driven by rising livestock production, zoonotic disease prevalence, and growing demand for advanced veterinary care. Key players include Zoetis, Boehringer Ingelheim, Elanco, MSD Animal Health, and local firms like AECI Animal Health. Advancements in vaccines, diagnostics, and digital livestock monitoring are shaping the sector. For instance, in July 2024, Nutreco acquired Chemfit Fine Chemicals Proprietary Ltd., trading as AECI Animal Health in South Africa, strengthening its presence in the region’s animal nutrition and health sector. Government initiatives to improve biosecurity and local vaccine production further strengthen growth, while increasing e-commerce adoption and veterinary telehealth expand accessibility and market penetration.
Key South Africa Animal Health Company Insights
South Africa’s animal health market is led by global players like Zoetis, MSD Animal Health, Elanco, and Boehringer Ingelheim, alongside local firms such as AECI Animal Health. These companies dominate through strong distribution, vaccine innovation, diagnostics, and tailored livestock solutions, holding significant market share across production and companion animal segments.
Key South Africa Animal Health Companies:
- Boehringer Ingelheim International GmbH
- Zoetis Services LLC
- Merck & Co., Inc.
- Elanco
- Virbac
- Ceva Santé Animale
- Dechra
- Phibro Animal Health Corporation
- Bimeda Corporate (Afrivet)
- Bupo Animal Health (Pty) Ltd
- Vetoquinol
- IDEXX
- Avimune Inc.
- Afrigen Biologics and Vaccines
- Deltamune
Recent Developments
-
In July 2025, the Agricultural Research Council (ARC) initiated the establishment of a domestic Foot-and-Mouth Disease (FMD) vaccine production facility, aiming to reduce reliance on imports and ensure quicker, localized vaccine supply for South Africa and the Southern African region.
-
In 2024 and ongoing, the International Vaccine Institute (IVI) collaborated with South African market players has partnered with Biovac and Afrigen Biologics to advance vaccine production and clinical trials including oral cholera vaccine technology transfer, hepatitis E vaccine safety studies, and Rift Valley fever immunogenicity assay development.
-
in July 2023, A.L.P.H.A. Plus initiative, led by Zoetis and PHARMAQ, expanded sustainable livestock care across Sub-Saharan Africa, including tilapia, advancing aquaculture health through vaccines, diagnostics, and management, while scaling veterinary services and productivity.
South Africa Animal Health Market Report Scope
Report Attribute
Details
Market size in 2025
USD 1.02 billion
Revenue forecast in 2033
USD 1.80 billion
Growth rate
CAGR of 7.4% from 2025 to 2033
Historical data
2021 - 2023
Base year
2024
Forecast period
2025 - 2033
Quantitative units
Revenue in USD million/billion and CAGR from 2025 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Product, animal, disease, distribution channel, and end use
Key companies profiled
Boehringer Ingelheim International GmbH; Zoetis Services LLC; Merck & Co., Inc.; Elanco; Ceva Santé Animale; Phibro Animal Health Corporation; Bimeda Corporate; Virbac; Bupo Animal Health (Pty) Ltd; Vetoquinol; Dechra; IDEXX; Avimune Inc.; Afrigen Biologics and Vaccines; Deltamune
Customization scope
Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
South Africa Animal Health Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the South Africa Animal Health market report based on product, animal, disease, distribution channel, and end use.
-
Animal Outlook (Revenue, USD Million, 2021 - 2033)
-
Production Animals
-
Poultry
-
Swine
-
Cattle
-
Sheep & Goats
-
Fish
-
-
Companion Animals
-
Dogs
-
Cats
-
Horses
-
Pet Birds
-
Others
-
-
-
Product Outlook (Revenue, USD Million, 2021 - 2033)
-
Biologics
-
Vaccines
-
Modified/ Attenuated Live
-
Inactivated (Killed)
-
Other Vaccines
-
-
Other Biologics
-
-
Pharmaceuticals
-
Parasiticides
-
Anti-infectives
-
Anti-inflammatory
-
Analgesics
-
Others
-
-
Medicated Feed Additives
-
Diagnostics
-
Consumables, reagents and kits
-
Instruments and devices
-
-
Equipment & Disposables
-
Critical Care Consumables
-
Anesthesia Equipment
-
Fluid Management Equipment
-
Temperature Management Equipment
-
Rescue & Resuscitation Equipment
-
Research Equipment
-
Patient Monitoring Equipment
-
-
Others
-
Veterinary Telehealth
-
Veterinary Software
-
Livestock Monitoring
-
-
-
Disease Outlook (Revenue, USD Million, 2021 - 2033)
-
Poultry Diseases
-
Avian Influenza
-
Salmonellosis
-
Coccidiosis
-
Infectious Bronchitis
-
Others
-
-
Swine Diseases
-
Porcine Reproductive and Respiratory Syndrome (PRRS)
-
African Swine Fever
-
Salmonellosis
-
Porcine Circovirus (PCV)
-
Others
-
-
Cattle Diseases
-
Bovine Respiratory Disease (BRD)
-
Mastitis
-
Foot and Mouth Disease (FMD)
-
Bovine Viral Diarrhoea (BVD)
-
Others
-
-
Sheep & Goat Diseases
-
Bacterial Diseases
-
Parasitic Diseases
-
Viral Diseases
-
Others
-
-
Fish/Aquaculture Diseases
-
Bacterial Diseases
-
Parasitic Diseases
-
Others
-
-
Canine Diseases
-
Gastrointestinal
-
Neurological
-
Ophthalmic
-
Others
-
-
Feline Diseases
-
Gastrointestinal
-
Neurological
-
Ophthalmic
-
Others
-
-
Equine Diseases
-
Gastrointestinal
-
Neurological
-
Ophthalmic
-
Others
-
-
Pet Bird Diseases
-
Gastrointestinal
-
Ophthalmic
-
Others
-
-
Other Companion Animal Diseases
-
Gastrointestinal
-
Ophthalmic
-
Others
-
-
-
Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
-
Retail
-
E-Commerce
-
Hospital/ Clinic Pharmacy
-
-
End Use Outlook (Revenue, USD Million, 2021 - 2033)
-
Veterinary Reference Laboratories
-
Point-of-care Testing/In-house Testing
-
Veterinary Hospitals & Clinics
-
Others
-
Frequently Asked Questions About This Report
b. The South Africa animal health market size was estimated at USD 0.96 billion in 2024 and is expected to reach USD 1.02 billion in 2025.
b. The South Africa animal health market is expected to grow at a compound annual growth rate of 7.36% from 2025 to 2033 to reach USD 1.81 billion by 2033.
b. Production animals stand as both the largest and fastest-growing segment of South Africa’s animal health market, driven by the country’s strong dependence on livestock for food security, economic growth, and exports. Cattle, poultry, sheep, and goats are central to the agricultural economy, supporting millions of smallholders and commercial farmers. Rising domestic demand for protein-rich foods such as meat, milk, and eggs, coupled with expanding export opportunities, continues to fuel this segment’s growth.
b. Some key players operating in the South Africa animal health market include Boehringer Ingelheim International GmbH, Zoetis Services LLC, Merck & Co., Inc., Elanco, Ceva Santé Animale, Phibro Animal Health Corporation, Hipra, Bimeda Corporate, Virbac, Bupo Animal Health (Pty) Ltd, Vetoquinol, IDEXX, Avimune Inc., Afrigen Biologics and Vaccines, Deltamune
b. Key factors that are driving the market growth include rising awareness of zoonotic and emerging diseases, increasing aquaculture and poultry production and government regulations and disease control programs.
Share this report with your colleague or friend.
Need a Tailored Report?
Customize this report to your needs — add regions, segments, or data points, with 20% free customization.
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
Trusted market insights - try a free sample
See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.